Since 2014
Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria
Farmeconomia
View Archive Info| Field | Value | |
| Title |
Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria
|
|
| Creator |
Costa, Francesco Vittorio
|
|
| Subject |
Pharmacoeconomics; Health economics
Valsartan; Angiotensin II receptor blockers; Health cost |
|
| Description |
The search for a more specific and complete blockade of the hypertensive effects of angiotensin and of better tolerability than ACE-inhibitors has led to the development of angiotensin II receptor blockers (ARBs). ARBs have been evaluated in several large studies in terms of efficacy and safety in reducing blood pressure, as well as for cardiovascular and renal protection. Among angiotensin II receptor blockers, valsartan and losartan have the greatest number of therapeutic indications. In light of the costs related to cardiovascular disorder valsartan represents a potential long-term health cost saving strategy. Furthermore valsartan shows one of the lowest costs for patient achieving blood pressure goals and the higher level of persistence in its class.
|
|
| Publisher |
SEEd Medical Publishers
|
|
| Date |
2011-03-15
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — |
|
| Format |
application/pdf
|
|
| Identifier |
https://journals.edizioniseed.it/index.php/FE/article/view/997
10.7175/fe.v12i1S.997 |
|
| Source |
Farmeconomia. Health economics and therapeutic pathways; Vol 12, No 1S (2011); 9-17
2240-256X |
|
| Language |
eng
|
|
| Relation |
https://journals.edizioniseed.it/index.php/FE/article/view/997/1215
|
|
| Rights |
Copyright (c) 2011 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0 |
|